The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18

Immunity

Volumn 11, Issue 5, 1999, Pages 603-613

  Chapman, Tara L ^a   Heikema, Astrid P ^a   Bjorkman, Pamela J ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ALLELE; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; COMPETITIVE INHIBITION; HUMAN CYTOMEGALOVIRUS; IMMUNOREACTIVITY; INSECT; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR BINDING; VIRUS IMMUNITY;

EID: 0033229761     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80135-1     Document Type: Article

References (37)

1. Bebbington, C.R., and Hentschel, C.C.G. (1987). The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells. In DNA Cloning: A Practical Approach, D.M. Glover, ed. (Oxford: IRL Press), pp. 163-188.
2. Beck, S., and Barrell, B.G. (1988). Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 331, 269-272.
3. Bjorkman, P.J., and Parham, P. (1990). Structure, function and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 90, 253-288.
4. Borges, L., Hsu, M.L., Fanger, N., Kubin, M., and Cosman, D. (1997). A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159, 5192-5196.
5. Braud, V.M., Allan, D.S.J., Wilson, D., and McMichael, A.J. (1997). TAP-and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8, 1-10.
6. Browne, H., Smith, G., Beck, S., and Minson, T. (1990). A complex between the MHC class I homologue encloded by human cytomegalovirus and β2 microglobulin. Nature 347, 770-772.
7. Chapman, T.L., and Bjorkman, P.J. (1998). Characterization of a murine cytomegalovirus class I MHC homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 72, 460-466.
8. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M., and Lopez-Botet, M. (1997). A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186, 1809-1818.
9. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L., and Hsu, M.-L. (1997). A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273-282.
10. Davis, S.J., Michael, J., Puklavec, D.A., Ashford, K.H., Jones, E.Y., Stuart, D.I., and Williams, A.F. (1993). Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. Protein Eng. 6, 229-232.
11. Fahnestock, M.L., Tamir, I., Narhi, L., and Bjorkman, P.J. (1992). Thermal stability comparison of purified empty and peptide filled forms of a class I MHC molecule. Science 258, 1658-1662.
12. Fahnestock, M.L., Johnson, J.L., Feldman, R.M.R., Neveu, J.M., Lane, W.S., and Bjorkman, P.J. (1995). The MHC class l homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3, 583-590.
13. Fan, Q.R., Mosyak, L., Winter, C.C., Wagtmann, N., Long, E.O., and Wiley, D.C. (1997). Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389, 96-100.
14. Fanger, N.A., Cosman, D., Peterson, L., Braddy, S.C., Maliszewski, C.R., and Borges, L. (1998). The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28, 3423-3434.
15. Garboczi, D.N., Ursula, U., Ghosh, P., Seth, A., Kim, J., VanTienhoven, E.A.E., Biddison, W.E., and Wiley, D.C. (1996). Assembly, specific binding, and crystallization of a human TCR-αβ with an antigenic tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J. Immunol. 157, 5403-5410.
16. Hansen, J.C., Lebowitz, J., and Demeler, B. (1994). Analytical ultra-centrifugation of complex macromolecular systems. Biochemistry 33, 13155-13163.
17. Jenkins, N., Parekh, R.B., and James, D.C. (1996). Getting the glycosylation right - implications for the biotechnology industry. Nat. Biotech. 14, 975-981.
18. Karlsson, R., and Fält, A. (1997). Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J. Immunol. Methods 200, 121-133.
19. Kim, J., Chwae, Y.J., Kim, M.Y., Choi, I.H., Park, J.H., and Kim, S.J. (1997). Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J. Immunol. 159, 3875-3882.
20. Kuziemko, G.M., Stroh, M., and Stevens, R.C. (1996). Cholera Toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. Biochemistry 35, 6375-6384.
21. Lanier, L.L., Corliss, B., and Phillips, J.H. (1997). Arousal and inhibition of human NK cells. Immunol. Rev. 155, 145-154.
22. Leahy, D.J. (1995). A structural view of CD4 and CD8. FASEB J. 9, 17-25.
23. Lebrón, J.A., Bennett, M.J., Vaughn, D.E., Chirino, A.J., Snow, P.M., Mintier, G.A., Feder, J.N., and Bjorkman, P.J. (1998). Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93, 111-123.
24. Lee, N., Malacko, A.R., Ishitani, A., Chen, M.C., Bajorath, J., Marquardt, H., and Geraghty, D.E. (1995). The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3, 591-600.
25. Leong, C.C., Chapman, T.L., Bjorkman, P.J., Formankova, D., Mocarski, E.S., Phillips, J.H., and Lanier, L.L. (1998). Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187, 1681-1687.
26. Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D.E., and Lopez-Botet, M. (1999). The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol 29, 277-283.
27. Parham, P., Barnstable, C.J., and Bodmer, W.F. (1979). Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C Antigens. J. Immunol. 123, 342-349.
28. Parham, P., Androlewicz, M.J., Holmes, N.J., and Rothenberg, B.E. (1983). Arginine-45 is a major part of the determinant of human β2-microglobulin recognized by mouse monoclonal antibody BBM.1. J. Biol. Chem. 258, 6179-6186.
29. Raghavan, M., Lebrón, J.A., Johnson, J.L., and Bjorkman, P.J. (1996). Extended repertoire of permissible peptide ligands for HLA-B*2702. Prot. Sci. 5, 2080-2088.
30. Sánchez, L.M., Chirino, A.J., and Bjorkman, P.J. (1999). Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules. Science 283, 1914-1919.
31. Sidney, J., Del Guercio, M.F., Southwood, S., Engelhard, V.H., Appella, E., Rammensee, H.G., Falk, K., Rotzchke, O., Takiguchi, M., Kubo, R.T., et al. (1995). Several HLA alleles share overlapping peptide specificities. J. Immunol. 154, 247-259.
32. Valés-Gómez, M., Reyburn, H.T., Mandelboim, M., and Strominger, J.L. (1998). Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors (erratum). Immunity 9, U9-U9.
33. Vitale, M., Castriconi, R., Parolini, S., Pende, D., Hsu, M.L., Moretta, L., Cosman, D., and Moretta, A. (1999). The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Int. Immunol. 11, 29-35.
34. Wentworth, B.B., and Alexander, E.R. (1971). Seroepidemiology of infectious due to members of the herpesvirus group. Am. J. Epidemiol. 94, 496-507.
35. Wiertz, E., Hill, A., Tortorella, D., and Ploegh, H. (1997). Cytomegalo-viruses use multiple mechanisms to elude the host immune response. Immunol. Lett. 57, 213-216.
36. Wiley, D. (1988). MHC gene in cytomegalovirus. Nature 331, 209-210.
37. Zamyatnin, A.A. (1972). Protein volume in solution. Prog. Biophys. Mol. Biol. 24, 107-123.